vs
Side-by-side financial comparison of R F INDUSTRIES LTD (RFIL) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
R F INDUSTRIES LTD is the larger business by last-quarter revenue ($22.7M vs $20.4M, roughly 1.1× Sight Sciences, Inc.). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -20.4%, a 21.2% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs 6.9%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $-2.0M). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs 2.9%).
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
RFIL vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.7M | $20.4M |
| Net Profit | $173.0K | $-4.2M |
| Gross Margin | 36.8% | 87.3% |
| Operating Margin | 4.0% | -18.0% |
| Net Margin | 0.8% | -20.4% |
| Revenue YoY | 22.9% | 6.9% |
| Net Profit YoY | 172.7% | 64.9% |
| EPS (diluted) | $0.01 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.7M | $20.4M | ||
| Q3 25 | $19.8M | $19.9M | ||
| Q2 25 | $18.9M | $19.6M | ||
| Q1 25 | $19.2M | $17.5M | ||
| Q4 24 | $18.5M | $19.1M | ||
| Q3 24 | $16.8M | $20.2M | ||
| Q2 24 | $16.1M | $21.4M | ||
| Q1 24 | $13.5M | $19.3M |
| Q4 25 | $173.0K | $-4.2M | ||
| Q3 25 | $392.0K | $-8.2M | ||
| Q2 25 | $-245.0K | $-11.9M | ||
| Q1 25 | $-245.0K | $-14.2M | ||
| Q4 24 | $-238.0K | $-11.8M | ||
| Q3 24 | $-705.0K | $-11.1M | ||
| Q2 24 | $-4.3M | $-12.3M | ||
| Q1 24 | $-1.4M | $-16.3M |
| Q4 25 | 36.8% | 87.3% | ||
| Q3 25 | 34.0% | 86.4% | ||
| Q2 25 | 31.5% | 84.8% | ||
| Q1 25 | 29.8% | 86.2% | ||
| Q4 24 | 31.3% | 86.8% | ||
| Q3 24 | 29.5% | 83.9% | ||
| Q2 24 | 29.9% | 85.8% | ||
| Q1 24 | 24.5% | 85.5% |
| Q4 25 | 4.0% | -18.0% | ||
| Q3 25 | 3.6% | -39.7% | ||
| Q2 25 | 0.6% | -59.6% | ||
| Q1 25 | 0.3% | -79.2% | ||
| Q4 24 | 0.5% | -62.5% | ||
| Q3 24 | -2.5% | -55.7% | ||
| Q2 24 | -2.6% | -59.2% | ||
| Q1 24 | -15.5% | -76.4% |
| Q4 25 | 0.8% | -20.4% | ||
| Q3 25 | 2.0% | -41.0% | ||
| Q2 25 | -1.3% | -61.0% | ||
| Q1 25 | -1.3% | -80.8% | ||
| Q4 24 | -1.3% | -62.1% | ||
| Q3 24 | -4.2% | -54.9% | ||
| Q2 24 | -26.7% | -57.7% | ||
| Q1 24 | -10.1% | -84.4% |
| Q4 25 | $0.01 | $-0.07 | ||
| Q3 25 | $0.04 | $-0.16 | ||
| Q2 25 | $-0.02 | $-0.23 | ||
| Q1 25 | $-0.02 | $-0.28 | ||
| Q4 24 | $-0.02 | $-0.23 | ||
| Q3 24 | $-0.07 | $-0.22 | ||
| Q2 24 | $-0.41 | $-0.25 | ||
| Q1 24 | $-0.13 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $35.2M | $63.9M |
| Total Assets | $73.0M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $92.0M | ||
| Q3 25 | $3.0M | $92.4M | ||
| Q2 25 | $3.6M | $101.5M | ||
| Q1 25 | $1.3M | $108.8M | ||
| Q4 24 | $839.0K | $120.4M | ||
| Q3 24 | $1.8M | $118.6M | ||
| Q2 24 | $1.4M | $118.2M | ||
| Q1 24 | $4.5M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $35.2M | $63.9M | ||
| Q3 25 | $34.8M | $64.3M | ||
| Q2 25 | $34.2M | $70.0M | ||
| Q1 25 | $34.2M | $77.6M | ||
| Q4 24 | $34.1M | $87.5M | ||
| Q3 24 | $34.1M | $95.0M | ||
| Q2 24 | $34.6M | $101.6M | ||
| Q1 24 | $38.7M | $109.2M |
| Q4 25 | $73.0M | $115.3M | ||
| Q3 25 | $73.2M | $116.3M | ||
| Q2 25 | $72.7M | $122.0M | ||
| Q1 25 | $70.4M | $129.7M | ||
| Q4 24 | $71.0M | $142.8M | ||
| Q3 24 | $71.9M | $143.6M | ||
| Q2 24 | $72.8M | $149.7M | ||
| Q1 24 | $79.1M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.1M | $-1.8M |
| Free Cash FlowOCF − Capex | $2.0M | $-2.0M |
| FCF MarginFCF / Revenue | 9.0% | -9.7% |
| Capex IntensityCapex / Revenue | 0.3% | 0.8% |
| Cash ConversionOCF / Net Profit | 12.13× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.1M | $-1.8M | ||
| Q3 25 | $-311.0K | $-8.7M | ||
| Q2 25 | $2.2M | $-7.5M | ||
| Q1 25 | $601.0K | $-11.6M | ||
| Q4 24 | $-244.0K | $-3.5M | ||
| Q3 24 | $2.4M | $362.0K | ||
| Q2 24 | $197.0K | $-9.5M | ||
| Q1 24 | $840.0K | $-9.8M |
| Q4 25 | $2.0M | $-2.0M | ||
| Q3 25 | $-419.0K | $-8.9M | ||
| Q2 25 | $2.2M | $-7.8M | ||
| Q1 25 | $574.0K | — | ||
| Q4 24 | $-418.0K | $-3.6M | ||
| Q3 24 | $2.1M | $311.0K | ||
| Q2 24 | $28.0K | $-9.5M | ||
| Q1 24 | $697.0K | $-9.9M |
| Q4 25 | 9.0% | -9.7% | ||
| Q3 25 | -2.1% | -44.7% | ||
| Q2 25 | 11.4% | -39.6% | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | -2.3% | -18.9% | ||
| Q3 24 | 12.6% | 1.5% | ||
| Q2 24 | 0.2% | -44.7% | ||
| Q1 24 | 5.2% | -51.4% |
| Q4 25 | 0.3% | 0.8% | ||
| Q3 25 | 0.5% | 0.9% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.9% | 0.7% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 1.0% | 0.4% | ||
| Q1 24 | 1.1% | 0.6% |
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
